Brief: Celldex Therapeutics Q2 EPS USD -0.65
08/08/2023 21:41
Aug 8 (Reuters) - Celldex Therapeutics Q2 revenue USD 268 thousand vs. IBES estimate USD 528 thousand. * Q2 operating income USD -33.205 million * Q2 net income USD -30.502 million * Q2 EPS USD -0.65
Recent news on Celldex Therapeutics
See all newsUS RESEARCH ROUNDUP- Allstate, Autozone, Vertex Pharmaceuticals
U.S. STOCKS ON THE MOVE-Greenland Mines, GameStop, Shopify
Celldex shares slip as safety concerns cloud skin drug trial win (updated)
Celldex falls after two probable anaphylaxis cases in trials
Celldex's skin disease drug meets goals in two late-stage trials